Ledger.Open graph →
SEC Form D · Amendment · filed May 30, 2024

ECM Therapeutics, Inc

Offering
$30.0M
Sold
$26.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARRENDALE, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lindsey F. Saldin · Warrendale, PAExecChristine F. Sheehy · Warrendale, PAExecStephen F. Badylak · Warrendale, PAExec · DirectorPaul F. Fagan · Warrendale, PAExec · DirectorGeorge F. Hussey · Warrendale, PAExecJenna F. Dziki · Warrendale, PAExecKatie F. Collins · Warrendale, PAExec · DirectorEdward S. Rayner · Cambridge, MAExec · DirectorStephen S. Ramsthaler · New York, NYExecPeter Birch · Chatham, Ontario, CanadaExecOneFund Investments, LLC · San Francisco, CAExecVinay S. Mohta · Cambridge, MAExecJami S. O'Toole · Cambridge, MAExec · DirectorErin S. Osborn · Cambridge, MAExec · DirectorGrady Collins · Austin, TXExecRomney Navarro · Austin, TXExecHerbert B. Stern · Palm Beach Gardens, FLExec · DirectorDouglas B. Wolf · Palm Beach Gardens, FLExec · DirectorCorey B. Siegel · Palm Beach Gardens, FLExec · DirectorFrank B. Peabody · Palm Beach Gardens, FLExecThomas E. Mcgrath · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗